Source: PRLog

Press Release: Stemedica : Society for Neuroscience (SfN) Selects Stemedica International's Research as a Hot Topic

Latest preclinical data regarding the effects of Stemedica's proprietary stem cells on Alzheimer's disease to be publicized

Read full article »
Stemedica's Competitors | Stemedica's News | Stemedica's Financials
Stay up-to-date with the latest news on Stemedica
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Maynard A. Howe's photo - CEO of Stemedica

CEO

Maynard A. Howe

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Stemedica